JNJ Updates: Imodium Recalls; Heading For Chinese Acquisitions; Zytiga’s Success
May 23rd, 2012 by Trefis Team
Developing a new drug is a cumbersome process and can take up to 10 years. And often times many drugs have severe side-effects which go unnoticed during the trials. Almost all pharma companies have faced litigation against their drugs and subsequ...
Investing in Weight Loss Ahead of This Summer’s FDA Decisions
May 23rd, 2012 by Daniel Tarockoff
Submitted by Daniel Tarockoff as part of our contributors program . With the approaching FDA decisions for Vivus (NASDAQ: VVUS) and Arena Pharmaceuticals (NASDAQ: ARNA) this summer, many investors have begun looking for sympathy stocks in the we...
DirecTV’s Still Got Plenty Of Growth In A Saturated Market
May 23rd, 2012 by Trefis Team
As DirecTV (NASDAQ:DTV) battles increasing competition and a saturating U.S. pay-TV market, it still represents an attractive investment given its focus on financial metrics and diversification of risk with international expansion. It had a good ...
Why Perfect World Is Worth $24
May 23rd, 2012 by Trefis Team
Perfect World (NASDAQ:PWRD) is one of the top online gaming companies in China where it competes with the likes of NetEase (NASDAQ:NTES), Tencent, Shanda Interactive, Giant Interactive, and ChangYou. It also operates localized versions of its gam...
Olympics, Global Sporting Events Drive Nike’s Near-Term Growth
May 23rd, 2012 by Trefis Team
Nike Inc. (NYSE:NKE) is the largest manufacturer of athletic footwear, apparel and equipment worldwide by sales with close to $23 billion in revenues in 2011, far ahead of players like Adidas AG (FRA:ADS), Puma (ETR:PUM), K-swiss Inc. (NASDAQ:KS...
H.J. Heinz’s Earnings To Show Growth But Slimmer Margins
May 23rd, 2012 by Trefis Team
H.J. Heinz Company (NYSE:HNZ) is scheduled to announce its Q4 earnings on April 24. We expect the revenue growth to be driven by ketchup and sauces as the company leverages its brand name in emerging economies and extends its portfolio of product...
SunPower Could Get Some U.S. Duties On Chinese Imports
May 23rd, 2012 by Trefis Team
The solar industry witnessed another major event with the U.S. Commerce Department deciding to impose tariffs exceeding 30% on major Chinese panel manufacturers. The tariffs could help SunPower Corp. (NASDAQ:SPWR) improve its pricing in the Ameri...
Delta Plans Fleet Upgrade Through Southwest’s Jets
May 23rd, 2012 by Trefis Team
Delta Air Lines (NYSE:DAL) is aiming to replace its unprofitable regional jets with Boeing 717s to cut down fuel costs and help attain productivity gains. The carrier has entered into a tentative agreement with Southwest Airlines (NYSE:LUV) to pr...
It’s High Time For The Wireless Industry To Consolidate
May 23rd, 2012 by Trefis Team
With growth slowing in a saturated wireless market and growing concerns about the duopolistic environment that the industry is heading towards, some of the smaller incumbents may be looking for ways to consolidate and grow through acquisitions. W...
India Expects to Boost Solar Installations in New Five Year Plan
May 23rd, 2012 by Trefis Team
The Indian government has released a plan to aggressively promote renewables over the next 5 years. The plan calls for the country to double its present power generation capacity from renewable sources. It also aims to add 10 GW of solar installa...
Pharma Updates: Pfizer Recalls Advil & Merck’s Propecia Causes Furor
May 23rd, 2012 by Trefis Team
Pfizer (NYSE:PFE) recently recalled 65,000 bottles of Advil Liqui-Gels as they had strong odor due to over-processing of an ingredient in the medicine. Separately, Merck (NYSE:MRK) is facing widespread furor over Propecia, a hair growth drug. Pro...
MGM Resorts Plans To Launch A Social Gaming Website
May 23rd, 2012 by Trefis Team
Casino veteran MGM Resorts International (NYSE:MGM) is working on launching a social gaming website in order to grab share of the growing social gaming market. According to Lazard Capital, the social gaming industry will be worth $9 billion by 20...
JNJ Updates: Positives For Xarelto & Simponi
May 23rd, 2012 by Trefis Team
Johnson & Johnson ‘s (NYSE:JNJ) drug Simponi has shown improved results for inflammatory-bowel disease ulcerative colitis, according to a new clinical trial. This is an additional indication for Simponi over its already approved uses fo...
Buying VIX Calls as a Portfolio Hedge
May 23rd, 2012 by Investing Daily
Submitted by Investing Daily as part of our contributors program . Buying VIX Calls as a Portfolio Hedge By: Jim Fink Because VIX calls are based on VIX futures instead of the more volatile “spot” VIX, in the past I suggested th...
Facebook’s Relationship Status With Nasdaq: It’s Complicated
May 23rd, 2012 by Trefis Team
After months of speculation, the highly anticipated initial public offering of social network giant, Facebook, turned out to be a disaster for Nasdaq OMX Group (NASDAQ:NDAQ) as glitches in the software used by the exchange to establish a price ca...
